Biotechnology & Advanced Therapies eQMS
Fast-Growth Compliance for Cell, Gene, and Biologics Innovators
Designed for fast-scaling biotech startups moving from pre-clinical research (GLP) through clinical trials (GCP) to early commercial manufacturing. Scale from 10 to 500+ employees without licensing penalties.
What Gets Activated Instantly at Onboarding
Pre-Seeded Industry Roles
- Principal Investigator (PI)
- Study Director
- Quality Assurance Auditor
- Clinical QA Lead
Document Types & Numbering
- Study Protocols
- Standard Operating Procedures
- Certificate of Analysis (CoA)
- Bioanalytical Methods
Risk Assessment Matrix
Dynamic 3x3 / 5x5 Clinical Risk Matrix
Pre-Built Workflow Lifecycles
Protocol Amendment Governance, Clinical Deviation Triage, Multi-Site Study Audits
Operational Advantages for Your Sector
Ensure 100% data integrity for IND, BLA, and clinical trial submissions.
Early Adopter Program offers up to 70% subsidy for Series A–C biotech startups.
Deploy in 8–12 weeks to satisfy investor due diligence and regulatory audits.
Multi-tenant sandbox environment for safe process experimentation before production.
Launch Your Turnkey Biotechnology & Advanced Therapies eQMS
See the exact pre-configured GxP workflows, templates, and qualification evidence designed for your sector.